Ginette 2,0 mg/ 0,035 mg FC tablets

Ginette 2,0 mg/ 0,035 mg FC tablets

S4
PDF Leaflet Revision Date: 10 November 2022


Clinical Summary

Quick overview from the medicine insert

Indication

Oral contraception and anti-androgen therapy in women.

Dosage (summary)

One tablet daily, starting on the first day of the menstrual cycle.

Special Populations

  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy; may reduce milk production during lactation.

Key Drug Interactions

  • Hepatic enzyme inducers
  • Anticonvulsants
  • Antibiotics

Contraindications

  • Pregnancy
  • Breast cancer
  • Severe hepatic disease
  • Thrombo-embolic disorders

Common side effects

  • Headache
  • Depressed mood
  • Breast tenderness

Counselling Points

  • Take at the same time daily
  • Use additional contraception if missed dose
  • Monitor for mood changes

Serious warnings

  • Increased risk of thromboembolism
  • Not for use in smokers over 35

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Ginette 2,0 mg/ 0,035 mg FC tablets
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW